BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24816996)

  • 21. Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity.
    Marini MA; Fiorentino TV; Andreozzi F; Mannino GC; Perticone M; Sciacqua A; Perticone F; Sesti G
    Acta Diabetol; 2017 Aug; 54(8):775-784. PubMed ID: 28577138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic control affects plasma lipid and apolipoprotein levels in women, but not in men, with IDDM.
    Benzi L; Marchetti P; Giampietro O; Miccoli R; Pecori N; Sanna G; Caricato F; Giovannitti MG; Ciccarone AM; Navalesi R
    Acta Diabetol Lat; 1988; 25(2):149-54. PubMed ID: 3223190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
    al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
    Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.
    Boersma HE; van Waateringe RP; van der Klauw MM; Graaff R; Paterson AD; Smit AJ; Wolffenbuttel BHR
    BMC Endocr Disord; 2021 Jan; 21(1):14. PubMed ID: 33435948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.
    Ozata M; Gungor D; Turan M; Ozisik G; Bingol N; Ozgurtas T; Ozdemir IC
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction.
    Janghorbani M; Almasi SZ; Amini M
    Acta Diabetol; 2015 Aug; 52(4):781-8. PubMed ID: 25572334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes.
    Taskinen MR; Barter PJ; Ehnholm C; Sullivan DR; Mann K; Simes J; Best JD; Hamwood S; Keech AC;
    Diabetologia; 2010 Sep; 53(9):1846-55. PubMed ID: 20526762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
    Bae JC; Han JM; Kwon S; Jee JH; Yu TY; Lee MK; Kim JH
    Atherosclerosis; 2016 Aug; 251():170-176. PubMed ID: 27341533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Strategies for early detection of the risk of type II (non-insulin-dependent) diabetes in 1st degree relatives of patients with this disease].
    Kasperska-Czyzykowa T; Jedynasty K; Jaskólska-Ładosz K; Stefański P; Milczarczyk A
    Pol Arch Med Wewn; 2001 Sep; 106(3):801-7. PubMed ID: 11928589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The positive association of branched-chain amino acids and metabolic dyslipidemia in Chinese Han population.
    Yang P; Hu W; Fu Z; Sun L; Zhou Y; Gong Y; Yang T; Zhou H
    Lipids Health Dis; 2016 Jul; 15():120. PubMed ID: 27457614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population.
    Ley SH; Harris SB; Connelly PW; Mamakeesick M; Gittelsohn J; Wolever TM; Hegele RA; Zinman B; Hanley AJ
    Clin Chem; 2010 Apr; 56(4):666-70. PubMed ID: 20110448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
    Henninger J; Hammarstedt A; Rawshani A; Eliasson B
    BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes.
    Hanefeld M; Koehler C; Henkel E; Fuecker K; Schaper F; Temelkova-Kurktschiev T
    Diabet Med; 2000 Dec; 17(12):835-40. PubMed ID: 11168325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of multiple lipoprotein and apolipoprotein measures with worsening of glycemia and incident type 2 diabetes in 6607 non-diabetic Finnish men.
    Fizelova M; Miilunpohja M; Kangas AJ; Soininen P; Kuusisto J; Ala-Korpela M; Laakso M; Stančáková A
    Atherosclerosis; 2015 May; 240(1):272-7. PubMed ID: 25818853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HbA1c Cutoff Point of 5.9% Better Identifies High Risk of Progression to Diabetes among Chinese Adults: Results from a Retrospective Cohort Study.
    Liang K; Wang C; Yan F; Wang L; He T; Zhang X; Li C; Yang W; Ma Z; Ma A; Hou X; Chen L
    J Diabetes Res; 2018; 2018():7486493. PubMed ID: 30009184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can metabolic control variables of diabetic patients predict their quality of life?
    Dogan H; Harman E; Kocoglu H; Sargin G
    J Am Soc Hypertens; 2016 Jan; 10(1):81-8. PubMed ID: 26850525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.
    Jiang R; Schulze MB; Li T; Rifai N; Stampfer MJ; Rimm EB; Hu FB
    Diabetes Care; 2004 Aug; 27(8):1991-7. PubMed ID: 15277429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ramadan fasting on glycemic control and other essential variables in diabetic patients.
    Bener A; A Al-Hamaq AOA; Öztürk M; Çatan F; Haris PI; Rajput KU; Ömer A
    Ann Afr Med; 2018; 17(4):196-202. PubMed ID: 30588933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Study of Effects of Pioglitazone and Rosiglitazone on Various Parameters in Patients of Type-2 Diabetes Mellitus with Special Reference to Lipid Profile.
    Sharma SK; Verma SH
    J Assoc Physicians India; 2016 Sep; 64(9):24-28. PubMed ID: 27762511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.